His primary areas of study are Prostate cancer, Genetics, Genome-wide association study, Single-nucleotide polymorphism and Cancer. His Prostate cancer study is concerned with Internal medicine in general. His studies examine the connections between Internal medicine and genetics, as well as such issues in Gynecology, with regards to Gene mutation, Prostate biopsy, Prostate cancer screening and Prostate-specific antigen.
His Genome-wide association study research incorporates themes from Linkage disequilibrium, Genetic association, Locus and Genetic epidemiology. He has included themes like Odds ratio, Genotyping, Case-control study and Allele in his Single-nucleotide polymorphism study. His Cancer research incorporates elements of DNA Mutational Analysis and Immunology.
His primary areas of investigation include Prostate cancer, Internal medicine, Oncology, Genome-wide association study and Genetics. His biological study spans a wide range of topics, including Single-nucleotide polymorphism, Genotype, Case-control study and Prostate. His study in Single-nucleotide polymorphism is interdisciplinary in nature, drawing from both Genotyping, Genetic variation and Bioinformatics.
As a member of one scientific family, Zsofia Kote-Jarai mostly works in the field of Oncology, focusing on Germline and, on occasion, DNA repair. His research investigates the connection between Genome-wide association study and topics such as Genetic association that intersect with problems in Heritability and 1000 Genomes Project. His study looks at the relationship between Cancer and fields such as Cancer research, as well as how they intersect with chemical problems.
Zsofia Kote-Jarai mainly focuses on Prostate cancer, Internal medicine, Oncology, Genome-wide association study and Genetic association. His Prostate cancer research is multidisciplinary, relying on both Prostate, Gene, DNA repair, Hazard ratio and Single-nucleotide polymorphism. The study incorporates disciplines such as Proportional hazards model and Genetic variation in addition to Single-nucleotide polymorphism.
The various areas that Zsofia Kote-Jarai examines in his Oncology study include Germline mutation, Genetic predisposition, Relative risk, Germline and Stage. His research on Genome-wide association study is centered around Genetics and Genotype. His studies in Genetic association integrate themes in fields like Imputation, Breast cancer and Gene expression.
Zsofia Kote-Jarai mostly deals with Prostate cancer, Genome-wide association study, Internal medicine, Oncology and Genetic association. His Prostate cancer study integrates concerns from other disciplines, such as Cancer research, Prostate, Disease and Gene, DNA repair. Genetics covers he research in Genome-wide association study.
In the field of Internal medicine, his study on Relative risk, Cancer and Prostate cancer screening overlaps with subjects such as Risk assessment. His studies deal with areas such as Prostate-specific antigen, Germline mutation and Genotype as well as Oncology. His Genetic association study combines topics from a wide range of disciplines, such as Imputation, Odds ratio, Computational biology and SNP.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The evolutionary history of lethal metastatic prostate cancer.
Gunes Gundem;Peter Van Loo;Peter Van Loo;Peter Van Loo;Barbara Kremeyer;Ludmil B. Alexandrov.
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants
Nilah M M. Ioannidis;Joseph H H. Rothstein;Joseph H H. Rothstein;Vikas Pejaver;Sumit Middha.
American Journal of Human Genetics (2016)
Multiple newly identified loci associated with prostate cancer susceptibility.
Rosalind A Eeles;Rosalind A Eeles;Zsofia Kote-Jarai;Graham G Giles;Graham G Giles;Ali Amin Al Olama.
Nature Genetics (2008)
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro;Chee Goh;David Olmos;Ed Saunders.
Journal of Clinical Oncology (2013)
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
Rosalind A. Eeles;Ali Amin Al Olama;Sara Benlloch;Edward J. Saunders.
Nature Genetics (2013)
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch.
Nature Genetics (2018)
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
Rosalind A. Eeles;Zsofia Kote-Jarai;Ali Amin Al Olama;Graham G. Giles;Graham G. Giles.
Nature Genetics (2009)
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Ali Amin Al Olama;Zsofia Kote-Jarai;Sonja I. Berndt;David V. Conti.
Nature Genetics (2014)
Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene
Stephen M. Edwards;Zsofia Kote-Jarai;Julia Meitz;Rifat Hamoudi.
American Journal of Human Genetics (2003)
Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
Colin S Cooper;Colin S Cooper;Rosalind Eeles;Rosalind Eeles;David C Wedge;Peter Van Loo;Peter Van Loo;Peter Van Loo.
Nature Genetics (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: